Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Rodeberg

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Pediatric Blood & Cancer|May 22, 2018
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsVeronique Minard-Colin, David Walterhouse, Gianni Bisogno, et al.
Pediatric Blood & Cancer|November 27, 2020
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groupsSoledad Gallego, Yueh-Yun Chi, Gian Luca De Salvo, et al.
Cancer Medicine|December 19, 2020
Metabolic response as assessed by <sup>18</sup> F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeDouglas J Harrison, Yueh-Yun Chi, Jing Tian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative GroupsDavid O Walterhouse, Donald A Barkauskas, David Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology GroupLynn Million, Andrea Hayes-Jordan, Yueh-Yun Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupDouglas S Hawkins, Yueh-Yun Chi, James R Anderson, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Pediatric Blood & Cancer|May 22, 2018
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsVeronique Minard-Colin, David Walterhouse, Gianni Bisogno, et al.
Pediatric Blood & Cancer|November 27, 2020
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groupsSoledad Gallego, Yueh-Yun Chi, Gian Luca De Salvo, et al.
Cancer Medicine|December 19, 2020
Metabolic response as assessed by <sup>18</sup> F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeDouglas J Harrison, Yueh-Yun Chi, Jing Tian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative GroupsDavid O Walterhouse, Donald A Barkauskas, David Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2021
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology GroupLynn Million, Andrea Hayes-Jordan, Yueh-Yun Chi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology GroupDouglas S Hawkins, Yueh-Yun Chi, James R Anderson, et al.
Pageof 7